Numbers of specialty combinations (itemsets)^a for one-stop visits^b at different minimal supports for visit frequency of an itemset, stratified by number of specialties in an itemset.

a<p>Subsets of specialties visited by a patient at the same health care facility on the same day.</p>b<p>One-stop visits were defined as more than one ambulatory care visits for different specialties at the same healthcare facility on the same day by a patient.</p

Patterns of two-specialty combinations in one-stop visits^a in 2005 (selected).

a<p>One-stop visits were defined as more than one ambulatory care visits for different specialties at the same healthcare facility on the same day by a patient.</p>b<p>Total times of one-stop visits.</p>c<p>One patient might have more than one different combinations.</p

Numbers of visits and patients in all one-stop visits^a in 2005, stratified by consulted specialty (selected).

a<p>One-stop visits were defined as more than one ambulatory care visits for different specialties at the same healthcare facility on the same day by a patient.</p>b<p>The total visit counts of all one-stop visits.</p

Distribution of patients with one-stop visits^a in 2005, stratified by age and sex.

a<p>One-stop visits were defined as more than one ambulatory care visits for different specialties at the same healthcare facility on the same day by a patient.</p

Patterns of three-specialty combinations in one-stop visits^a in 2005 (selected).

a<p>One-stop visits were defined as more than one ambulatory care visits for different specialties at the same healthcare facility on the same day by a patient.</p>b<p>Total times of one-stop visits.</p>c<p>One patient might have more than one different combinations.</p

A comparison of 2-year Kaplan–Meier survival curves of PLA patients with and without septic ocular or CNS complications (p = 0.502, by log-rank test).

<p>A comparison of 2-year Kaplan–Meier survival curves of PLA patients with and without septic ocular or CNS complications (p = 0.502, by log-rank test).</p

A comparison of 2-year Kaplan–Meier survival curves of PLA patients aged <65 years and a Charlson comorbidity index ≤1 (i.e. between 0 and 1) with and without septic ocular or CNS complications (p = 0.001, by log-rank test).

<p>A comparison of 2-year Kaplan–Meier survival curves of PLA patients aged <65 years and a Charlson comorbidity index ≤1 (i.e. between 0 and 1) with and without septic ocular or CNS complications (p = 0.001, by log-rank test).</p

Clinical characteristics of PLA patients with and without septic ocular or central nervous system complications.

<p><b>NOTE.</b> PLA, pyogenic liver abscess.</p

The frequency of PLA cases with septic ocular or central nervous system complications.

<p><b>NOTE.</b> PLA, pyogenic liver abscess.</p

Countries that published more than 15 GPRD studies between 1995 and 2009 ranked by the number of GPRD studies per million inhabitants.

<p>Values in parentheses are rankings. SCI, Scientific Citation Index.</p